Challenges Facing microRNA Therapeutics for Cystic Fibrosis Lung Disease

Epigenomics - United Kingdom
doi 10.2217/epi-2019-0395
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd

Related search

Origins of Cystic Fibrosis Lung Disease

New England Journal of Medicine
Medicine
2015English

Targeting the Lung: Challenges in Gene Therapy for Cystic Fibrosis

2013English

CXCR1andCXCR2haplotypes Synergistically Modulate Cystic Fibrosis Lung Disease

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2011English

Genetic Influences on Cystic Fibrosis Lung Disease Severity

Frontiers in Pharmacology
Pharmacology
2013English

Elucidating Progression of Early Cystic Fibrosis Lung Disease

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2017English

Celiac Disease and Cystic Fibrosis: Challenges to Differential Diagnosis

Folia Medica
Medicine
2016English

Measuring and Improving Respiratory Outcomes in Cystic Fibrosis Lung Disease: Opportunities and Challenges to Therapy

Journal of Cystic Fibrosis
Child HealthPulmonaryPediatricsPerinatologyRespiratory Medicine
2010English

Cell Therapy for Cystic Fibrosis Lung Disease: Regenerative Basal Cell Amplification

Stem cells translational medicine
MedicineDevelopmental BiologyCell Biology
2018English

Risk Factors for Lung Disease Progression in Children With Cystic Fibrosis

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy